Cymbalta eases chemo-linked pain, study finds

04/3/2013 | HealthDay News

A study of patients with chemotherapy-related peripheral neuropathy showed 59% of those who took the antidepressant drug Cymbalta reported some pain relief, while 38% of those in the placebo group saw improvement. The results were published in the Journal of the American Medical Association.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX